Finally, our ability to reveal the mechanisms underlying histological transformation in the presented case was limited because only one recurrent tumor specimen was obtained, which limited the assessment of KRAS, NRAS, and BRAF codon alterations, and additional tumor genomic analysis to identify the unique combination of mutations of various oncogenes or epigenes contributing to transformation to SRCC was not performed. This evidence concerns the gene KRAS and neoplasm.